Zobrazeno 1 - 10
of 412
pro vyhledávání: '"Peter G Rose"'
Autor:
Peter G. Rose
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101458- (2024)
Externí odkaz:
https://doaj.org/article/96fa6c8067134acdbc4eefb435d1f62d
Autor:
Hussein Al-Sudani, Ying Ni, Philip Jones, Huseyin Karakilic, Lei Cui, Lisa D. S. Johnson, Peter G. Rose, Alexander Olawaiye, Robert P. Edwards, Robert A. Uger, Gloria H. Y. Lin, Haider Mahdi
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract The objective was to correlate CD47 gene expression with resistance to immune checkpoint inhibitors (ICI) in tumor tissue of gynecological cancer (GC). Further, we sought to assess the efficacy of targeting CD47 pathway alone and in combinat
Externí odkaz:
https://doaj.org/article/b9d424df472742e596767037c39f4aad
Autor:
Denise Uyar, Chad M. Michener, Erin Bishop, Elizabeth Hopp, Pippa Simpson, Liyun Zhang, Janet S. Rader, Peter G. Rose, Haider S. Mahdi, Robert Debernardo, Qiana Christian, William Bradley
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveIncompletely resected epithelial ovarian cancer represents a poor prognostic subset of patients. Novel treatment strategies are needed to improve outcomes for this population. We evaluated a treatment strategy combining platinum-based chemot
Externí odkaz:
https://doaj.org/article/1ac9e64e1d2a4a97b07806f67364b141
Autor:
Goutam Dey, Rashmi Bharti, Chad Braley, Ravi Alluri, Emily Esakov, Katie Crean-Tate, Keith McCrae, Amy Joehlin-Price, Peter G. Rose, Justin Lathia, Zihua Gong, Ofer Reizes
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-19 (2023)
Abstract Poly-ADP Ribose Polymerase (PARP) targeted therapy is clinically approved for the treatment of homologous recombination (HR) repair deficient tumors. The remarkable success of this therapy in the treatment of HR repair deficient cancers has
Externí odkaz:
https://doaj.org/article/2717acaed3114fb5964d7b172163769d
Autor:
Peter G. Rose
Publikováno v:
Gynecologic Oncology Reports, Vol 50, Iss , Pp 101311- (2023)
Externí odkaz:
https://doaj.org/article/8c67418010ab4096b008a41afd069c88
Publikováno v:
Gynecologic Oncology Reports, Vol 50, Iss , Pp 101303- (2023)
To evaluate the efficacy of the combination of pembrolizumab and lenvatinib in MMR deficient (dMMR) endometrial cancer (EC) patients who previously failed to respond to single-agent pembrolizumab. A retrospective review of MMR deficient endometrial c
Externí odkaz:
https://doaj.org/article/ac8e3f48d1ce49899cacd8de98a77a04
Autor:
Peter G. Rose
Delicious December mixes food and history in a celebration of Dutch and American Christmas traditions. In more than one hundred tried-and-true recipes, award-winning food historian Peter G. Rose draws on traditions that date back to the Middle Ages,
Autor:
Ying Ni, Ahmed Soliman, Amy Joehlin-Price, Peter G. Rose, Anda Vlad, Robert P. Edwards, Haider Mahdi
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Various immune signatures predictive of resistance to immune checkpoint inhibitors (ICI) have been described in multiple solid cancers, but still under-investigated in gynecological (GYN) cancer. For 49 GYN cancer patients included in our st
Externí odkaz:
https://doaj.org/article/3f72a09e25c04f2ea9c7be83e5af3188
Autor:
Katie K. Crean-Tate, Chad Braley, Goutam Dey, Emily Esakov, Caner Saygin, Alexandria Trestan, Daniel J. Silver, Soumya M. Turaga, Elizabeth V. Connor, Robert DeBernardo, Chad M. Michener, Peter G. Rose, Justin Lathia, Ofer Reizes
Publikováno v:
Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-10 (2021)
Abstract Background Ovarian cancer is the most fatal gynecologic malignancy in the United States. While chemotherapy is effective in the vast majority of ovarian cancer patients, recurrence and resistance to standard systemic therapy is nearly inevit
Externí odkaz:
https://doaj.org/article/a54de3d12f8b4ccea390d7aca3b1cc80
Autor:
Laura M. Chambers, Meng Yao, Molly Morton, Morgan Gruner, Anna Chichura, Anthony B. Costales, Max Horowitz, Peter G. Rose, Chad M. Michener, Robert Debernardo
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100951- (2022)
Objective (s): To evaluate travel distance in women with advanced or recurrent epithelial ovarian cancer (OC) undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) and the subsequent impact upon outcomes. Methods: An
Externí odkaz:
https://doaj.org/article/fee775c7d38845aca4c5ce4219ceedd8